Teva Launches $4.2 Billion Senior Notes Offering
Teva Pharmaceutical Industries is raising capital via the issuance of $4.2 billion in senior notes due between 2032 and 2037. The proceeds will likely be used for general corporate purposes.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day